PubMedCrossRef 51. Denning GM, Iyer SS, Reszka KJ, O’Malley Y, Rasmussen GT, Britigan BE: Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa , alters expression of immunomodulatory proteins by human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003, 285:L584-L592.PubMed 52. Ras GJ, Theron AJ, Anderson Tucidinostat solubility dmso R, Taylor GW, Wilson R, Cole PJ, van der Merwe CA: Enhanced release of elastase and oxidative inactivation of alpha-1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine. J Infect Dis 1992, 166:568–573.PubMedCrossRef 53. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ: Measurement of Pseudomonas

aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 1988, 56:2515–2517.PubMed 54. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C: Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC

Microbiol 2007, 7:45.PubMedCrossRef 55. Huang J, Xu Y, Zhang H, Li Y, Huang X, Ren B, Zhang X: Temperature-dependent expression of phzM and its regulatory genes lasI and ptsP in rhizosphere isolate Pseudomonas sp. strain M18. Appl Environ Microbiol 2009, 75:6568–6580.PubMedCrossRef 56. Reid DW, Lam www.selleckchem.com/products/pnd-1186-vs-4718.html QT, Schneider H, Walters EH: Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur Respir J 2004, 24:286–291.PubMedCrossRef 57. Lamont IL, Konings AF, Reid DW: Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Biometals 2009, 22:53–60.PubMedCrossRef 58. Palma M, Worgall S, Quadri LE: Transcriptome analysis of the Pseudomonas aeruginosa response to iron. Arch Microbiol 2003, 180:374–379.PubMedCrossRef 59. Manos J, Arthur J, Rose B, Tingpej P, Fung C, Curtis M, Webb JS, Hu H, Kjelleberg S, Gorrell MD, et al.: Transcriptome analyses and biofilm-forming mafosfamide characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. J Med Microbiol 2008, 57:1454–1465.PubMedCrossRef 60. Dalhoff A, Janjic N, Echols R: Redefining penems. Biochem Pharmacol 2006, 71:1085–1095.PubMedCrossRef

61. Chamberland S, Bayer AS, Schollaardt T, Wong SA, Bryan LE: Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother 1989, 33:624–634.PubMed 62. McPhee JB, Tamber S, Bains M, Maier E, Gellatly S, Lo A, Benz R, Hancock RE: The major outer membrane MLN2238 manufacturer protein OprG of Pseudomonas aeruginosa contributes to cytotoxicity and forms an anaerobically regulated, cation-selective channel. FEMS Microbiol Lett 2009, 296:241–247.PubMedCrossRef 63. Aires JR, Kohler T, Nikaido H, Plesiat P: Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 1999, 43:2624–2628.